Larry Biegelsen

Q: What is Larry Biegelsen's success rate?

Larry Biegelsen currently has a success rate of 87.41651735630086.

Q: What is the average return of Larry Biegelsen's calls?

Their stock ratings have generated an average return of 9.383292315890637.

Wells Fargo | Healthcare

Larry Biegelsen is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #1932 out of 4542 analysts, they have issued 63 stock ratings with a success rate of 87.42% and an average return of 9.38%.

Larry Biegelsen has a well-established track record, with 63 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 87.42% and an average return of 9.38%, underscoring their expertise and ability to identify winning opportunities for investors.

#1932

Out of 4542

Total Ratings

+87.42%

Success Rate

+9.38%

Average Return

Recent Ratings Analysis

INSP

Hold

Feb 12, 2026

Target

$145.00

Current

$59.65

Performance

0.00%

Larry Biegelsen rated INSP as Equal-Weight on Feb 12, 2026, setting a price target of 145. The Hold stance appears justified, as shares hovered around 59.65 with a 0.00% move.

ZBH

Hold

Feb 11, 2026

Target

$98.00

Current

$95.18

Performance

-0.45%

On Feb 11, 2026, ZBH was given a Equal-Weight rating by Larry Biegelsen, with a target price of 98. Market indecision, reflected in sideways trading near 95.18, supported the cautious call.

EW

Buy

Feb 11, 2026

Target

$100.00

Current

$76.44

Performance

-3.64%

EW received a Overweight rating from Larry Biegelsen on Feb 11, 2026, aiming for 100. Price action was muted, as shares hovered around 76.44 despite the bullish outlook.

BSX

Buy

Feb 05, 2026

Target

$94.00

Current

$74.12

Performance

-4.53%

On Feb 05, 2026, Larry Biegelsen published a Overweight outlook on BSX, with a target of 94. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 74.12.

GEHC

Buy

Feb 05, 2026

Target

$97.00

Current

$78.65

Performance

-4.45%

Larry Biegelsen on Feb 05, 2026 assigned GEHC a Overweight rating, with a price target of 97. The recommendation remains pending validation as shares consolidate around 78.65.

TFX

Hold

Jan 29, 2026

Target

$116.00

Current

$104.54

Performance

-0.89%

On Jan 29, 2026, Larry Biegelsen reaffirmed TFX with a Equal-Weight rating, targeting 116. The neutral call matched muted market action of -0.89%.

HTFL

Buy

Jan 28, 2026

Target

$38.00

Current

$22.49

Performance

-27.68%

HTFL was rated Overweight by Larry Biegelsen on Jan 28, 2026, with a price objective of 38. This case shows how bullish projections can fail, with the stock now below 22.49.

JNJ

Buy

Jan 22, 2026

Target

$240.00

Current

$244.55

Performance

11.93%

On Jan 22, 2026, Larry Biegelsen initiated coverage on JNJ with a Overweight rating and target of 240. The stock’s climb of 11.93% since the call highlights the foresight in the rating.

PEN

Hold

Jan 15, 2026

Target

$374.00

Current

$338.72

Performance

-3.36%

Larry Biegelsen issued a Equal-Weight recommendation for PEN on Jan 15, 2026, price target set at 374. The rating was appropriate for a consolidating market trading near 338.72.

KMTS

Buy

Dec 12, 2025

Target

$28.00

Current

$27.46

Performance

4.93%

On Dec 12, 2025, KMTS was evaluated by Larry Biegelsen, who gave a Overweight rating and target of 28. So far, the Buy call awaits clearer momentum, with shares flat at 27.46.

COO

Hold

Dec 05, 2025

Target

$82.00

Current

$81.70

Performance

0.37%

Larry Biegelsen rated COO as Equal-Weight on Dec 05, 2025, setting a price target of 82. The Hold stance appears justified, as shares hovered around 81.7 with a 0.37% move.

MDT

Buy

Nov 19, 2025

Target

$114.00

Current

$100.88

Performance

0.54%

On Nov 19, 2025, MDT was given a Overweight rating by Larry Biegelsen, with a target price of 114. The stock traded sideways with a 0.54% move, keeping the bullish thesis unresolved.

MMSI

Buy

Nov 14, 2025

Target

$95.00

Current

$78.86

Performance

-7.32%

MMSI received a Overweight rating from Larry Biegelsen on Nov 14, 2025, aiming for 95. The rating hasn’t played out as hoped, with the stock trading 7.32% below expectations.

BLCO

Hold

Nov 14, 2025

Target

$17.00

Current

$16.73

Performance

7.24%

On Nov 14, 2025, Larry Biegelsen published a Equal-Weight outlook on BLCO, with a target of 17. The Hold call missed some of the bullish momentum as shares advanced toward 17.

SYK

Buy

Nov 14, 2025

Target

$456.00

Current

$365.85

Performance

1.00%

Larry Biegelsen on Nov 14, 2025 assigned SYK a Overweight rating, with a price target of 456. The recommendation remains pending validation as shares consolidate around 365.85.

TNDM

Hold

Nov 07, 2025

Target

$14.00

Current

$18.69

Performance

14.94%

On Nov 07, 2025, Larry Biegelsen reaffirmed TNDM with a Equal-Weight rating, targeting 14. Market strength beyond 18.69 went further than the conservative outlook suggested.

RXST

Hold

Nov 06, 2025

Target

$10.00

Current

$7.80

Performance

-9.41%

RXST was rated Equal-Weight by Larry Biegelsen on Nov 06, 2025, with a price objective of 10. Investors who stayed cautious avoided some of the 9.41% decline.

DXCM

Buy

Oct 31, 2025

Target

$93.00

Current

$65.08

Performance

11.78%

On Oct 31, 2025, Larry Biegelsen initiated coverage on DXCM with a Overweight rating and target of 93. The stock’s climb of 11.78% since the call highlights the foresight in the rating.

GKOS

Buy

Oct 30, 2025

Target

$122.00

Current

$106.74

Performance

21.57%

Larry Biegelsen issued a Overweight recommendation for GKOS on Oct 30, 2025, price target set at 122. Investors following the Buy call captured upside momentum, with shares now at 106.74.

ISRG

Buy

Oct 22, 2025

Target

$600.00

Current

$478.60

Performance

-9.19%

On Oct 22, 2025, ISRG was evaluated by Larry Biegelsen, who gave a Overweight rating and target of 600. Investors saw limited payoff as shares fell short of the 600 target.

HYPR

Hold

Aug 15, 2025

Target

$0.85

Current

$1.09

Performance

-21.58%

Larry Biegelsen rated HYPR as Equal-Weight on Aug 15, 2025, setting a price target of 0.85. The cautious Hold call aligned with subsequent weakness, as shares slipped 21.58%.

ALC

Hold

Aug 06, 2025

Target

$93.00

Current

$78.55

Performance

-6.62%

On Aug 06, 2025, ALC was given a Equal-Weight rating by Larry Biegelsen, with a target price of 93. The rating provided protection from downside risk as the stock fell to 78.55.

BAX

Hold

Aug 01, 2025

Target

$24.00

Current

$18.71

Performance

-14.80%

BAX received a Equal-Weight rating from Larry Biegelsen on Aug 01, 2025, aiming for 24. The Hold stance proved prudent, with the market softening by 14.80%.

LUNG

Hold

Aug 01, 2025

Target

$3.00

Current

$1.42

Performance

-11.80%

On Aug 01, 2025, Larry Biegelsen published a Equal-Weight outlook on LUNG, with a target of 3. Weakness in the stock, now at 1.42, supported the conservative rating.

NVCR

Hold

Jul 25, 2025

Target

$14.50

Current

$12.53

Performance

4.07%

Larry Biegelsen on Jul 25, 2025 assigned NVCR a Equal-Weight rating, with a price target of 14.5. The Hold stance reflected consolidation, as shares held near 12.53.

NPCE

Buy

Jan 30, 2025

Target

$17.00

Current

$14.50

Performance

2.18%

On Jan 30, 2025, Larry Biegelsen reaffirmed NPCE with a Overweight rating, targeting 17. Market indecision has kept the 17 target in a holding pattern.

NARI

Hold

Jan 07, 2025

Target

$80.00

Current

$79.97

Performance

0.65%

NARI was rated Equal-Weight by Larry Biegelsen on Jan 07, 2025, with a price objective of 80. Flat performance suggests the Hold view was reasonable.

Frequency Asked Questions

Who is Larry Biegelsen?

Larry Biegelsen is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Larry Biegelsen's success rate?

Larry Biegelsen currently has a success rate of +87.42%.

How many ratings has Larry Biegelsen issued?

Larry Biegelsen has issued 63 stock ratings so far.

What is the average return of Larry Biegelsen's calls?

Their stock ratings have generated an average return of +9.38%.

What is Larry Biegelsen's ranking?

Larry Biegelsen is ranked #1932 out of 4542 analysts.

What types of ratings does Larry Biegelsen give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Larry Biegelsen?

You can follow Larry Biegelsen by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Larry Biegelsen?

Their latest rating was a Hold on INSP issued on 2026-02-12.